General MedicationsINJECTIONStandard
VIBATIV
TELAVANCIN
Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VIBATIV is listed in Drugs@FDA under application 022407 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TELAVANCIN Form and strength INJECTABLE; INJECTION - 250MG Sponsor THERAVANCE INC Submission history Latest submission status date: 2013-06-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview VIBATIV is listed in Drugs@FDA under application 022407 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TELAVANCIN Form and strength INJECTABLE; INJECTION - 250MG Sponsor THERAVANCE INC Submission history Latest submission status date: 2013-06-21 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.